1. Department of Hematology, Fujita Health University Hospital, Toyoake, Japan;
2. Department of Preventive Medicine, Kyushu University Faculty of Medical Sciences, Fukuoka, Japan;
3. Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan;
4. Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan;
5. Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan;
6. Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan;
7. Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital Tokyo, Tokyo, Japan;
8. Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan;
9. Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan;
10. Division of Molecular Therapy, The Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan;
11. Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan;
12. Department of HSCT Data Management and Biostatistics, Nagoya University Graduate School of Medicine, Nagoya, Japan;
13. Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan;
14. Department of Hematology and Oncology, Children’s Medical Center, Japanese Red Cross Nagoya First Hospital Nagoya, Japan; and
15. Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan